Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Medulloblastoma 1Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1

Interventions

Temozolomide 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2pembrolizumab 1palbociclib 1fimepinostat 1dostarlimab 1X-Rays 1Topotecan 1Radiotherapy 1Phantoms, Imaging 1PTC596 1Lomustine 1Irinotecan 1Etoposide 1Diffusion Tensor Imaging 1CUDC-907 1CLR1404 11-methyltryptophan 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Diffuse Intrinsic Pontine Glioma × fimepinostat × Clear all
NCT03893487 2025-07-11

PNOC016

University of California, San Francisco

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡